Bayer Aktiengesellschaft (BAYRY)
OTCMKTS · Delayed Price · Currency is USD
15.38
-0.05 (-0.32%)
Nov 18, 2026, 1:34 PM EST
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $60.56 billion as of November 18, 2026. Its market cap has increased by 90.19% in one year.
Market Cap
60.56B
Enterprise Value
97.96B
Revenue
51.97B
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 60.56B, an increase of 933.43%. That is a compound annual growth rate of 6.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2026 | 60.24B | 40.84% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 1.23B |
| Veradigm | 851.43M |
| American Oncology Network | 800.57M |
| Elite Pharmaceuticals | 398.16M |
| Nika Pharmaceuticals | 369.14M |
| CytoDyn | 366.94M |
| Northwest Biotherapeutics | 260.69M |
| Glorywin Entertainment Group | 234.77M |